Bradford D. Dahms
CIK 1787307 · Chief Financial Officer · last filed 2026-02-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$580.1K
Companies
3
Total Filings
12
Lifetime Open-Market Net
$30.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| JBIO | Chief Financial Officer | 37,813 | $15.34 | $580.1K | $0 | 2 | 2026-02-13 |
| Theseus Pharmaceuticals, Inc. (THRX) Delisted | President and CFO | 0 | $4.06 | $0 | $30.0K | 6 | 2024-02-14 |
| Cartesian Therapeutics, Inc. (SELB) Delisted | Chief Financial Officer | 38,000 | $0.88 | $33.5K | $0 | 4 | 2021-01-06 |
Recent Filings · Page 2 of 2
12 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-01-06 | Cartesian Therapeutics, Inc. (SELB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-09-05 | Cartesian Therapeutics, Inc. (SELB) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–12 of 12
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.